Home > Specialists > Hepatobiliary Surgery > Dr. Yong Yi (易勇)

Specialty & Clinical Focus:
Hepatobiliary surgeon at Zhongshan Hospital, Fudan University in Shanghai, specializing in minimally invasive and open surgery for primary and metastatic liver tumors, complex liver cancer and hilar cholangiocarcinoma resection, and conversion therapy for advanced liver cancer.
Professional Title & Qualifications:
Associate Chief Physician
Master's Supervisor
PhD in Surgery
Hospital & Department:
Shanghai Zhongshan Hospital, Fudan University – Department of Hepatobiliary Surgery
(address: No. 180 Fenglin Road, Xuhui District, Shanghai, 200032)
Dr. Yong Yi (易勇) - Hepatobiliary Surgeon
Personal Biography
Dr. Yong Yi (易勇), PhD in Surgery, is an Associate Chief Physician and Master's Supervisor in the Department of Liver Surgery at Zhongshan Hospital, Fudan University in Shanghai. His clinical work focuses on minimally invasive and open liver surgery for primary and metastatic liver tumors, complex liver cancer resection, hilar cholangiocarcinoma resection, and conversion therapy for advanced liver cancer. He has experience in more than 2,000 liver resection procedures and conducts basic and clinical research on liver cancer recurrence, metastasis, and the tumor microenvironment. He is also a member of the Liver Tumor Group of the Shanghai Medical Association's Hepatology Branch.
Why Choose Dr. Yong Yi for Your Hepatobiliary Care?
For international patients considering liver surgery in China, Dr. Yong Yi's focused hepatobiliary experience is particularly relevant when a case involves primary or metastatic liver tumors, complex liver cancer, hilar cholangiocarcinoma, or potential conversion therapy. As an Associate Chief Physician and Master's Supervisor in Liver Surgery at Zhongshan Hospital, Fudan University, he has experience in more than 2,000 liver resection procedures.
Dr. Yi performs minimally invasive laparoscopic and open liver surgery for both benign and malignant tumors. This breadth is useful for patients seeking a specialist review of imaging, pathology, prior treatment history and unresolved surgical questions before deciding whether an in-person pathway in Shanghai should be considered.
His research on the tumor microenvironment, liver cancer recurrence and metastasis, together with his role as principal investigator for National Natural Science Foundation of China projects, adds an academic dimension to his clinical work. A remote specialist review before travel can help patients identify the records and questions that matter most and prepare more clearly for the next step.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel to Shanghai, international patients can request MedBridgeNZ coordination for a pre-travel case review with Dr. Yong Yi. We help organize current imaging, pathology, medical reports, prior treatment history and a focused question list, coordinate translation where needed, and transfer the documentation to Zhongshan Hospital with the client's authorization.
Dr. Yi will review the submitted records and provide a specialist opinion, recommendations and responses to the patient's questions. MedBridgeNZ coordinates appointment communication and follow-up so the patient can understand the proposed next steps and practical travel requirements before deciding whether to pursue an in-person pathway in China.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Yong Yi
Areas of Expertise
Minimally invasive surgery for liver tumors (including primary liver cancer, metastatic liver cancer, hepatic hemangioma, and other benign and malignant liver tumors)
Hepatic cysts
Hepatic adenoma
Focal nodular hyperplasia (FNH)
Open surgery for liver tumors
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
1,800 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Associate Chief Physician & Master's Supervisor, Department of Liver Surgery, Zhongshan Hospital, Fudan University
Education & Training
Awards & Honors
Selected for the Shanghai Municipal Education Commission's "Chenguang Program" (2013)
Ministry of Education Natural Science Award - First Prize (2015)
Selected for the Shanghai Excellent Young Specialist Physician Training and Funding Program (2016)
Academic & Professional Memberships
Member, Liver Tumor Group, Hepatology Branch, Shanghai Medical Association
Research & Publications
Main research direction focuses on the tumor microenvironment and its role in liver cancer metastasis and recurrence.
Serves as the principal investigator for two projects funded by the National Natural Science Foundation of China (NSFC).
Published over 20 SCI papers as the first or corresponding author in prominent journals, including the Journal of Hepatology.
Selected Peer-Reviewed Publications
Yi Y, et al. Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study. Front Oncol. 2022;12:1046584. PMID: 36505772
Yi Y, et al. Laparoscopic versus open left hemihepatectomy for hepatocellular carcinoma: a propensity score matching analysis. Transl Cancer Res. 2020;9(9):5484–5492. PMID: 35117913
Yi Y, et al. MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K/AKT by translocating β-catenin and predicts poor prognosis. Liver Int. 2021;41(6):1409–1420. PMID: 33506565
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Yong Yi’s expertise relevant to my liver condition?
Dr. Yi’s stated clinical focus includes minimally invasive and open surgery for primary and metastatic liver tumors, hepatic hemangioma, hepatic cysts, hepatic adenoma, focal nodular hyperplasia, complex liver cancer, hilar cholangiocarcinoma, and conversion therapy for advanced liver cancer. To understand how this experience relates to an individual case, patients can begin with a remote specialist review of their current imaging, pathology, medical reports, prior treatment history and prepared questions. MedBridgeNZ coordinates the record preparation, translation and authorized document transfer for this review.
How can an international patient request an appointment with Dr. Yi?
International patients can submit an inquiry to MedBridgeNZ for remote specialist-review coordination or an in-person appointment request at Zhongshan Hospital, Fudan University. We coordinate the collection and organization of medical records, translation support where needed, client-authorized document transfer, and appointment communication with the relevant hospital office. The remote review allows Dr. Yi to provide an opinion and recommended next steps before travel. In-person appointment dates remain subject to the hospital’s scheduling process and the specialist’s availability.
What happens during a remote specialist review with Dr. Yong Yi?
During the remote specialist review, Dr. Yi will examine the submitted imaging, pathology and medical reports, then provide a specialist opinion, recommendations and responses to the patient’s prepared questions. Depending on the case, the opinion may discuss whether minimally invasive surgery, open resection or conversion therapy warrants further consideration, without predetermining an in-person treatment plan. MedBridgeNZ coordinates document preparation, translation and communication, while the medical opinion and recommendations are provided by Dr. Yi.
What support is available if I travel to Shanghai for hospital care?
After the remote review, patients who wish to pursue an in-person pathway in Shanghai can request MedBridgeNZ’s medical travel coordination support. Services can include appointment communication with Zhongshan Hospital, medical invitation or visa-document coordination support, travel and accommodation planning, translation coordination, and non-clinical bilingual administrative support during hospital visits. The scope is tailored to the patient’s itinerary and the hospital’s administrative requirements, helping reduce avoidable logistical uncertainty throughout the medical travel process.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a New Zealand–based medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis or treatment. Hospital, specialist, diagnostic, treatment and travel charges are third-party costs and remain separate unless a specific item is expressly included in writing.
